A Single Part, Four-Way Crossover, Randomized, Partially-Blinded Study to Evaluate the Effect of Intravenous ANG-3777 on Baseline-Adjusted QT/QTc Interval in the Fasted State in Healthy Male and Female Subjects
Latest Information Update: 21 Jun 2023
At a glance
- Drugs Terevalefim (Primary) ; Moxifloxacin
- Indications Acute kidney injury; Acute lung injury; Delayed graft function; Renal failure
- Focus Adverse reactions
- Sponsors Angion Biomedica; Elicio Therapeutics
- 01 Jun 2023 According to an Elicio Therapeutics media release, Angion Biomedica merged with the Elicio Therapeutics and the combined company is called as Elicio Therapeutics.
- 26 May 2021 New trial record